The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TRANSCEND CLL 004: Minimal residual disease (MRD) negative responses after lisocabtagene maraleucel (Liso-Cel; JCAR017), a CD19-directed CAR T cell product, in patients (pts) with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL).
 
Tanya Siddiqi
Consulting or Advisory Role - AstraZeneca; BeiGene; Juno Therapeutics; Pharmacyclics
Speakers' Bureau - Pharmacyclics/Janssen; Seagen
Research Funding - Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Oncternal Therapeutics (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Juno Therapeutics
 
Kathleen Anne Dorritie
Research Funding - Juno Therapeutics; Kite, a Gilead company
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Jacob Drobnyk Soumerai
Consulting or Advisory Role - Verastem
Research Funding - BeiGene (Inst); Genentech/Roche (Inst); TG Therapeutics (Inst)
 
Deborah Marie Stephens
Honoraria - Genentech
Research Funding - Acerta Pharma; Gilead Sciences; Karyopharm Therapeutics
 
Jason A Dubovsky
Employment - Celgene
Stock and Other Ownership Interests - Abbvie; Celgene
Research Funding - Celgene (Inst)
Patents, Royalties, Other Intellectual Property - Abbvie
Travel, Accommodations, Expenses - Celgene
Other Relationship - Celgene
 
Heidi H. Gillenwater
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Juno Therapeutics
 
Lucy Gong
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Jerill Thorpe
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Juno Therapeutics
 
Lin Yang
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Juno Therapeutics
 
William G. Wierda
Consulting or Advisory Role - Sanofi
Research Funding - Abbvie; Acerta Pharma; Cyclacel; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Loxo; miRagen; Oncternal Therapeutics, Inc; Pharmacyclics; Sunesis Pharmaceuticals; Xencor